Acenaphtho[1,2-b]pyrrole-based selective fibroblast growth factor receptors 1 (FGFR1) inhibitors: design, synthesis, and biological activity.
暂无分享,去创建一个
Honglin Li | Weiping Zhu | Yufang Xu | Xin Wang | Hua Xie | Linjiang Tong | Dong Kuang | Honglin Li | Xianwen Cao | Yufang Xu | Jian Ding | Lin-jiang Tong | X. Qian | Weiping Zhu | D. Kuang | Xuhong Qian | Zhuo Chen | Hua Xie | Xin Wang | Shaoying Tan | Jian Ding | Zhuo Chen | Xianwen Cao | Shaoying Tan | Yufang Xu
[2] X. Qian,et al. Design, synthesis, and antitumor evaluation of novel acenaphtho[1,2-b]pyrrole-carboxylic acid esters with amino chain substitution. , 2006, Bioorganic & medicinal chemistry.
[3] Zhichao Zhang,et al. 3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): structure-based design and structure-activity relationship studies. , 2011, Journal of medicinal chemistry.
[4] S. Hubbard,et al. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. , 1997, Science.
[5] K. Glaser,et al. 7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors. , 2008, Journal of medicinal chemistry.
[6] E. Dreassi,et al. Synthesis and biological evaluation of guanidino compounds endowed with subnanomolar affinity as competitive inhibitors of maize polyamine oxidase. , 2009, Journal of medicinal chemistry.
[7] K. Bland,et al. Differential responses by pancreatic carcinoma cell lines to prolonged exposure to Erbitux (IMC-C225) anti-EGFR antibody. , 2003, The Journal of surgical research.
[8] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[9] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[10] Zoe Cournia,et al. Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. , 2009, Journal of medicinal chemistry.
[11] Meredith C Henderson,et al. Characterization of Novel Diaryl Oxazole-Based Compounds as Potential Agents to Treat Pancreatic Cancer , 2009, Journal of Pharmacology and Experimental Therapeutics.
[12] V. Mersch-Sundermann,et al. Induction of apoptosis in tumor cells by naturally occurring sulfur-containing compounds. , 2005, Mutation research.
[13] X. Qian,et al. A new class of long-wavelength fluorophores: strong red fluorescence, convenient synthesis and easy derivation. , 2005, Chemical communications.
[14] M. Knowles,et al. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. , 2009, Cancer research.
[15] D. Fabbro,et al. Su-6668. SUGEN. , 2001, Current opinion in investigational drugs.
[16] S. Hubbard,et al. SU 6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors 1 , 2000 .
[17] A. Coskun,et al. An acenaphthopyrrolone-dipicolylamine derivative as a selective and sensitive chemosensor for group IIB cations , 2006 .
[18] Zigang Dong,et al. Cancer prevention research — then and now , 2009, Nature Reviews Cancer.
[19] Martin Stahl,et al. Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.
[20] S. Hubbard,et al. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain , 1998, The EMBO journal.
[21] W. Sommergruber,et al. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. , 2008, Cancer research.
[22] W. Hagmann,et al. The many roles for fluorine in medicinal chemistry. , 2008, Journal of medicinal chemistry.
[23] K. Parang,et al. Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase. , 2006, Journal of medicinal chemistry.
[24] N. Lemoine,et al. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer , 1994, International journal of cancer.
[25] M. Huang,et al. R16, a novel amonafide analogue, induces apoptosis and G2-M arrest via poisoning topoisomerase II , 2007, Molecular Cancer Therapeutics.
[26] L. Johnson,et al. Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.
[27] Yuan Zhao,et al. Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge , 2007, J. Chem. Inf. Model..
[28] Jian Ding,et al. GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms , 2009, Acta Pharmacologica Sinica.
[29] D. O'Hagan,et al. Fluorine in medicinal chemistry: A review of anti-cancer agents , 2006 .
[30] T. Seki,et al. Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells , 2008, Carcinogenesis.
[31] X. Qian,et al. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity. , 2006, Bioorganic & medicinal chemistry.
[32] Cheng Luo,et al. Discovery and SAR of thiazolidine-2,4-dione analogues as insulin-like growth factor-1 receptor (IGF-1R) inhibitors via hierarchical virtual screening. , 2010, Journal of medicinal chemistry.
[33] J. Fargnoli,et al. Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors. , 2005, Journal of medicinal chemistry.
[34] Xiaoyan Zhang,et al. A photostable fluorescent probe for targeted imaging of tumour cells possessing integrin alpha(v)beta(3). , 2009, Molecular bioSystems.
[35] Yufang Xu,et al. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis. , 2010, Journal of medicinal chemistry.
[36] X. Qian,et al. Novel Bcl‐2 Inhibitors: Discovery and Mechanism Study of Small Organic Apoptosis‐Inducing Agents , 2007, Chembiochem : a European journal of chemical biology.
[37] B. Delage,et al. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. , 2008, Carcinogenesis.
[38] Jian Ding,et al. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening. , 2008, Journal of medicinal chemistry.
[39] Kai Huang,et al. PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach , 2010, Nucleic Acids Res..
[40] A. Ullrich,et al. The discovery of receptor tyrosine kinases: targets for cancer therapy , 2004, Nature Reviews Cancer.
[41] J. Milner,et al. Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells. , 1997, Nutrition and cancer.
[42] Shishir Shishodia,et al. Molecular targets of dietary agents for prevention and therapy of cancer. , 2006, Biochemical pharmacology.
[43] M. Botta,et al. Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK). , 2003, Current pharmaceutical design.
[44] Tao Yi,et al. A highly selective fluorescence turn-on sensor for cysteine/homocysteine and its application in bioimaging. , 2007, Journal of the American Chemical Society.
[45] W. Hagmann,et al. The many roles for fluorine in medicinal chemistry. , 2008, Journal of medicinal chemistry.
[46] N. Gray,et al. Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.
[47] Yufang Xu,et al. Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells. , 2008, Bioorganic & medicinal chemistry.
[48] Hege S. Beard,et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.
[49] William L Jorgensen,et al. Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening. , 2010, Journal of medicinal chemistry.
[50] V. Stoll,et al. Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases. , 2009, Journal of medicinal chemistry.
[51] Qiang He,et al. Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway. , 2010, ACS medicinal chemistry letters.
[52] N. Turner,et al. Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.
[53] Pascal Furet,et al. Tyrosine kinase inhibitors: From rational design to clinical trials , 2001, Medicinal research reviews.
[54] Hualiang Jiang,et al. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. , 2007, Bioorganic & medicinal chemistry.
[55] S. Cook,et al. De-regulated FGF receptors as therapeutic targets in cancer. , 2010, Pharmacology & therapeutics.
[56] A. Kraft,et al. Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases. , 2009, Journal of medicinal chemistry.
[57] Scott B Ficarro,et al. A structure-guided approach to creating covalent FGFR inhibitors. , 2010, Chemistry & biology.